Cargando…
Detection and quantification of novel C‐terminal TDP‐43 fragments in ALS‐TDP
The pathological hallmark of amyotrophic lateral sclerosis (ALS) is the presence of cytoplasmic inclusions, containing C‐terminal fragments of the protein TDP‐43. Here, we tested the hypothesis that highly sensitive mass spectrometry with parallel reaction monitoring (MS‐PRM) can generate a high‐res...
Autores principales: | Feneberg, Emily, Charles, Philip D., Finelli, Mattéa J., Scott, Connor, Kessler, Benedikt M., Fischer, Roman, Ansorge, Olaf, Gray, Elizabeth, Talbot, Kevin, Turner, Martin R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8412074/ https://www.ncbi.nlm.nih.gov/pubmed/33300249 http://dx.doi.org/10.1111/bpa.12923 |
Ejemplares similares
-
Towards a TDP-43-Based Biomarker for ALS and FTLD
por: Feneberg, Emily, et al.
Publicado: (2018) -
The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
por: Berning, Britt A., et al.
Publicado: (2019) -
TDP-43 expression in mouse models of amyotrophic lateral sclerosis and spinal muscular atrophy
por: Turner, Bradley J, et al.
Publicado: (2008) -
TDP-43 Proteinopathy Specific Biomarker Development
por: Cordts, Isabell, et al.
Publicado: (2023) -
Oxr1 improves pathogenic cellular features of ALS-associated FUS and TDP-43 mutations
por: Finelli, Mattéa J., et al.
Publicado: (2015)